一分钟看懂
这是一项关于Adrenal Cortical Carcinoma的II 期研究，登记的药物或干预包括Cabozantinib；Cabozantinib S-malate；Pharmacological Study，当前状态为研究进行中，已停止招募。登记地点显示中国Birmingham、Anchorage、Little Rock、Anaheim等城市有研究中心记录。是否仍有名额以及是否值得进一步询问，需要向研究中心确认。
药物或干预
Cabozantinib；Cabozantinib S-malate；Pharmacological Study · II 期
中国哪些地方有记录
以下地点来自登记信息，不代表此刻仍有名额；请向研究中心确认最新情况。
- Children's Hospital of Alabama · Birmingham
- Providence Alaska Medical Center · Anchorage
- Arkansas Children's Hospital · Little Rock
- Kaiser Permanente-Anaheim · Anaheim
- Kaiser Permanente-Bellflower · Bellflower
- Kaiser Permanente Downey Medical Center · Downey
- Kaiser Permanente-Fontana · Fontana
- Loma Linda University Medical Center · Loma Linda
- Children's Hospital Los Angeles · Los Angeles
- Kaiser Permanente Los Angeles Medical Center · Los Angeles
- Valley Children's Hospital · Madera
- UCSF Benioff Children's Hospital Oakland · Oakland
- Kaiser Permanente-Oakland · Oakland
- Children's Hospital of Orange County · Orange
- Lucile Packard Children's Hospital Stanford University · Palo Alto
- University of California Davis Comprehensive Cancer Center · Sacramento
- Kaiser Permanente-Rio San Diego · San Diego
- Rady Children's Hospital - San Diego · San Diego
- UCSF Medical Center-Mission Bay · San Francisco
- Children's Hospital Colorado · Aurora
- Rocky Mountain Hospital for Children-Presbyterian Saint Luke's Medical Center · Denver
- Connecticut Children's Medical Center · Hartford
- Yale University · New Haven
- Alfred I duPont Hospital for Children · Wilmington
- Kaiser Permanente-Capitol Hill Medical Center · Washington D.C.
- MedStar Georgetown University Hospital · Washington D.C.
- Children's National Medical Center · Washington D.C.
- Golisano Children's Hospital of Southwest Florida · Fort Myers
- UF Health Cancer Institute - Gainesville · Gainesville
- Nemours Children's Clinic-Jacksonville · Jacksonville
公开的入选条件
- * Upper age limit of =\< 18 years of age for medullary thyroid carcinoma (MTC), renal cell carcinoma (RCC) and hepatocellular carcinoma (HCC) =\< 30 years for all other diagnoses
- * Patients must have a body surface area \>= 0.35 m\^2
- * Patients must have recurrent or refractory disease, or newly diagnosed disease with no known curative therapy or therapy proven to prolong survival with an acceptable quality of life; patients must have had histologic verification of one of the malignancies
- Ewing sarcoma
- Rhabdomyosarcoma (RMS)
- Non-rhabdomyosarcoma soft tissue sarcomas (STS) including microphthalmia transcription factor associated STS (alveolar soft part sarcoma \[ASPS\] and clear cell sarcoma \[CCS\])
- Osteosarcoma
- Wilms tumor
联系前需要确认
请继续确认中心是否启动、疾病分型、既往治疗、检查费用和知情同意安排。
查看登记信息
登记号：NCT02867592；登记信息更新于 2026-08-28。